Rewers, Marian
,
Hyöty, Heikki
Lernmark, Åke
Hagopian, William
She, Jin-Xiong
Schatz, Desmond
Ziegler, Anette-G
Toppari, Jorma
Akolkar, Beena
Krischer, Jeffrey
Funding for this research was provided by:
National Institute of Diabetes and Digestive and Kidney Diseases (U01 DK63829, U01 DK63861, U01 DK63821, U01 DK63865, U01 DK63863, U01 DK63836, U01 DK63790, UC4 DK63829, UC4 DK63861, UC4 DK63821, UC4 DK63865, UC4 DK63863, UC4 DK63836, UC4 DK95300, UC4 DK100238, UC4 DK106955, UC4 DK112243, UC4 DK117483, HHSN267200700014C)
National Center for Advancing Translational Sciences (UL1 TR000064, UL1 TR001082)
Article History
First Online: 23 October 2018
Compliance with Ethical Standards
:
: Marian Rewers, William Hagopian, Jin-Xiong She, Desmond Schatz, Anette-G Ziegler, Beena Akolkar, and Jeffrey Krischer declare that they have no conflict of interest.Heikki Hyöty reports grants from National Institute of Health (NIH) to carry out the TEDDY study; and being a Shareholder and member of the board of Vactech Ltd., which develops vaccines against picornaviruses.Ake Lernmark is a Member of the Scientific Advisory Board of Diamyd Medical AB, Stockholm, Sweden.Jorma Toppari reports grants from NIH/NIDDK.
: This article does not contain any studies with human or animal subjects performed by any of the authors. The TEDDY study was approved by local institutional review or ethics boards at each site (University of Washington, Seattle; University of Colorado; Medical College of Georgia, Augusta; University of South Florida, Tampa; University of Turku, Finland; Technische Universitat, Munich, Germany; Lund University, Malmo, Sweden) and is monitored by an External Evaluation Committee formed by the National Institutes of Health.